Eli Lilly (LLY) Debt Ratio (2009 - 2026)
Eli Lilly (LLY) posted Debt Ratio of 0.37 for Q1 2026, down 1.55% quarter-over-quarter from 0.38 in Q4 2025, and down 13.66% year-on-year from 0.43 in Q1 2025.
Eli Lilly (LLY) Debt Ratio (2009 - 2026) Analysis & Trends
Eli Lilly (LLY) has reported Debt Ratio for 18 consecutive years, with 0.37 the latest figure, recorded in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.37, down 13.66% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.37 (down 13.66% YoY), and the FY2025 annual result was 0.38, down 11.59% from the prior year.
- Debt Ratio was 0.37 for Q1 2026 at Eli Lilly, down from 0.38 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.43 in Q1 2025 and troughed at 0.33 in Q4 2022.
- Average Debt Ratio over 5 years is 0.38, with a median of 0.37 recorded in 2026.
- Year-over-year, Debt Ratio increased 20.11% in 2023 and decreased 13.66% in 2026.
- Over 5 years, Debt Ratio stood at 0.33 in 2022, then climbed by 20.11% to 0.39 in 2023, then rose by 8.45% to 0.43 in 2024, then declined by 11.59% to 0.38 in 2025, then fell by 1.55% to 0.37 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.37 in Q1 2026, 0.38 in Q4 2025, and 0.37 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.37 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.27 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.47 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | -0.21 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.38 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.62 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.39 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.31 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.37 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | 0.43 |
| Dec 31, 2024 | 0.43 |
| Sep 30, 2024 | 0.41 |
| Jun 30, 2024 | 0.40 |
| Mar 31, 2024 | 0.41 |
| Dec 31, 2023 | 0.39 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.34 |
| Mar 31, 2023 | 0.36 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | 0.36 |
| Mar 31, 2022 | 0.35 |
| Dec 31, 2021 | 0.35 |
| Sep 30, 2021 | 0.35 |
| Jun 30, 2021 | 0.35 |